Sweden’s Pharmadule AB Signed Contract with Servac Philippines Inc to Produce Anti-Rabies Vaccine

President Gloria Macapagal-Arroyo witnessed on December 6, 2007  the signing of a memorandum of agreement (MOA) between Servac Philippines Inc. and Sweden’s Pharmadule AB (PDH) on the construction of a $120-million pharmaceutical pilot factory in Alabang, Muntinlupa City, Metro Manila for the manufacture of anti-rabies vaccine.
The MOA states that in “order to arrive at a fixed price for the supply of the pilot plant, PDH will perform a Basic Design study under a separate contract for the design, supply, reassemble and start-up of the process plant and certain services associated therewith.”
PDH is a Swedish company specializing in the design and construction of advanced modular production facilities for the pharmaceutical and biotech industries. It has delivered more than 50 facilities to clients, including Merck, Eli Lilly, Genetech, AstraZeneca, Baxter and Pharmacia.
The quotation includes the supply and construction of a pharmaceutical plant based on modular fabrication as well as the supply of technical expertise.
The Servac-PDH contract also involves the supply of modular equipment for the installation of a world-class vaccine production facility in the Philippines. When completed, the plant is expected to employ more than 100 persons.

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *